Absci (ABSI) Short term Debt (2020 - 2025)

Absci's (ABSI) quarterly Short term Debt came in at $12.8 million in Q3 2025, little changed quarter-over-quarter from $12.8 million in Q2 2025.

Absci (ABSI) Short term Debt (2020 - 2025) Analysis & Trends

Absci has disclosed Short term Debt across 4 years of filings, most recently posting $12.8 million for Q3 2025.

  • Short term Debt for Q3 2025 came in at $12.8 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $12.8 million (changed N/A YoY), and the FY2024 annual result was $12.8 million, changed 0.0% from the prior year.
  • Short term Debt came in at $12.8 million for Q3 2025 at Absci, roughly flat from $12.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $12.8 million in Q4 2023 to a low of $12.8 million in Q4 2023.
  • The 3-year median for Short term Debt is $12.8 million (2023), against an average of $12.8 million.
  • Peak annual rise in Short term Debt reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Absci's Short term Debt stood at $12.8 million in 2023, then changed by 0.0% to $12.8 million in 2024, then changed by 0.0% to $12.8 million in 2025.
  • The last three Short term Debt figures came in at $12.8 million (Q3 2025), $12.8 million (Q2 2025), and $12.8 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Absci 1.13 Bn 1.01 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 12.75 Mn
Jun 30, 2025 12.75 Mn
Mar 31, 2025 12.75 Mn
Dec 31, 2024 12.75 Mn
Dec 31, 2023 12.75 Mn
Dec 31, 2020 632,000.00